doi: 10.2337/diacare.21.9.1414 4 WhitingDRGuariguataLWeilCShawJ
A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway
It also enhances cellular insulin sensitivity , aiding glucose metabolism , controlling blood sugar , preventing insulin resistance , and reducing liver fat deposition
While some gallstones will sit harmlessly inside the gallbladder, for a minority of patients they will block the release of bile
In a statement to CNBC, Humana said it has 15 years of experience administering a temporary Medicare drug coverage program for low-income beneficiaries and will play a similar operational role in Bridge
Under close medical supervision, proactive, preventive-focused strategies like GLP-1 microdosing provide a preventive health strategy that extends benefits well beyond weight loss, supporting multiple systems and helping reduce the risk of chronic disease
